Roxana Mehran, MD
- PROFESSOR | Medicine, Cardiology
- PROFESSOR | Population Health Science and Policy
Specialties:
Cardiovascular Disease (Heart Disease), Cardiology (Heart)Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, FSCAI is Professor of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Wiener Cardiovascular Institute at Mount Sinai School of Medicine (icahn.mssm.edu/research/center-interventional-cardiology). Dr. Mehran completed her training in internal medicine at the University of Connecticut, where she was also a Chief Medical Resident, before continuing with Fellowships in Cardiovascular Disease and Interventional Cardiology at Mount Sinai Medical Center. Dr. Mehran is internationally recognized for her work as a clinical trial specialist with complex data analyses and outcomes research within the field of interventional cardiology and for her experience and expertise in working with regulatory agencies to conduct clinical trials.
Her research interests expand from mechanisms of restenosis to treatment and prevention of acute kidney injury in cardiac patients, as well as advancing treatments for acute coronary syndromes and acute myocardial infarction. In addition to founding a highly regarded academic research organization (ARO) within the Cardiovascular Research Foundation, she is also a widely published author and frequent invited speaker at national and international scientific conferences such as American Heart Association, American College of Cardiology, European Society of Cardiology, and EuroPCR. She has served as Course Co-Director of the annual Transcatheter Cardiovascular Therapeutics (TCT) for the last 13 years. Dr. Mehran serves on editorial board of multiple peer reviewed journals, including Journal of the American College of Cardiology, Circulation, and Circulation Research. She currently serves on the board of trustees of SCAI, as a member of the Program Committee for the American Heart Association Scientific Sessions, as a member of the board of directors for Harboring Hearts, and as Program Chair for Society of Cardiac Angiography and Interventions (SCAI- WIN (Women in Innovations)) Initiative, and is also the Chief Scientific Officer of the Clinical Trials Center at the Cardiovascular Research Foundation (NYC).
Clinical Focus
- Acute Coronary Syndrome
- Cardiac Catheterization
- Chest Pain
- Coronary Artery Disease
- Coronary Stenting
- High Blood Pressure
- High Cholesterol
- Hyperlipidemia
- Hypertension (High Blood Pressure)
Education
MD, St. George's University
Residency, Internal Medicine, InterCommunity Health Care
Residency, Internal Medicine, University of Connecticut School of Medicine GME
Fellowship, Cardiovascular Disease, Mount Sinai Hospital
Fellowship, Interventional Cardiology, Mount Sinai Hospital
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Mehran during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- American Medical Association (AMA)
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Elixir Medical Corporation; STEL
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- Alabama Chapter of ACC; Alberta Health; Asan University South Korea; Brazilian Cardiology Society; CVI philadelphia; Cedars-Sinai Medical Center; China Cardiology Conferene; Clinical Works; Encore Medical Education; Gaffney Events; Hoag Memorial Hospital, CA; Hong Kong Cardiology; Inova Health; Pavasca; Promedica International CME; Rhode Island Hospital (RIH); Rocederise; Rush University Medical Center; Rutgers, The State University of New Jersey; Society for Cardiovascular Angiography and Interventions (SCAI); St. Francis Hospital; Stamford Hospital; Sutter Bay Hospital, CA; TAIWAN CARDIOLOGY CONFERENCE; Transluminal Therapies; UNIVERSITY OF FLORENCE; University of Pennsylvania; WebMD; boston medical center; dignity health; european society of cardiology; medtelligence; precision pci
Scientific Advisory Board:
- American College of Cardiology
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.